Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Oral Solid Dosage Manufacturing Market is anticipated to grow at a steady pace by 2035, claims Roots Analysis

This image opens in the lightbox

News provided by

Roots Analysis

14 Jun, 2023, 15:00 GMT

Share this article

Share toX

Share this article

Share toX

The processing of complex oral solid dosage, from formulation design to scale-up and manufacturing is fraught with several challenges; as a result, drug developers are increasingly relying on service providers that offer integrated capabilities in this domain 

LONDON, June 14, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Oral Solid Dosage Manufacturing Market, 2023-2035" report to its list of offerings.

Service providers have introduced the latest upgrades in their portfolio in order to achieve a competitive edge. These upgrades primarily target upstream bottlenecks related to the development and oral solid dosage manufacturing, such as low solubility, poor bioavailability, bitter taste, and high potency. Further, they also aim to streamline the manufacturing of complex formulations, including fixed dose combinations, orally disintegrating tablets, minitablets, flavored chewables, and double-layered tablets.

To order this 490+ page report, which features 180+ figures and 210+ tables, please visit 
https://www.rootsanalysis.com/reports/oral-solid-dosage-manufacturing-market.html

Key Market Insights

Presently, nearly 570 players offer services for the oral solid dosage manufacturing

Nearly 50% of the service providers are based in the Asia-Pacific region, followed by the players located in Europe (29%). Further, this segment of the industry is dominated by the presence of mid-sized players (51-200 employees), which represent around 40% of the total number of contract manufacturers.

Nearly 15% players claim to act as one-stop shops, offering services, ranging from formulation and process development to analytical testing, scale-up, and oral solid dosage packaging

Most of the service providers (~60%) provide oral solid dosage primary packaging, followed by companies  offering early-stage formulation development services. Further, tablets and capsules emerged as the most popular dosage forms, being offered by most of the contract manufacturers.

Over 85 expansion initiatives were undertaken by contract manufacturers during the period 2018-2022

Majority of the projects (48%) were focused on expanding the capabilities related to oral solid dosage manufacturing, including handling highly potent oral solid dosage forms. Additionally, close to 50% of the total number of expansions were undertaken in North America.

Over 50% of the annual, global oral solid dosage manufacturing capacity belongs to very large players with over 10,000 employees

More than 50% of the installed capacity is dedicated to the manufacturing of tablets. In addition, 47% of the overall capacity is installed in Europe, followed by Asia-Pacific (32%).

Nearly 45% of the global outsourced commercial demand is anticipated to be driven by oral solids intended to target oncological indications

The global outsourced clinical demand is largely driven by phase III trials due to high patient enrollment and longer time duration of such trials. Further, our analysis suggests that the demand for outsourcing the oral solid dosage manufacturing in phase II trials is likely to grow at a relatively faster rate.

North America and Europe are anticipated to capture around 85% of the market share, till 2035

In terms of type of finished dosage form, the current market is driven by tablet manufacturing (close to 60%); this trend is unlikely to change in the foreseen future. Further, in terms of type of primary packaging, major share of the service revenues in 2035 is likely to be captured by bottles, followed by blister packaging for oral solids.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/oral-solid-dosage-manufacturing-market.html

Key Questions Answered

  • What is the global market size of oral solid dosage manufacturing market?
  • Which are the top players in the oral solid dosage manufacturing market?
  • How many contract service providers possess capabilities to handle oral solid therapies with highly potent APIs (HPAPIs)?
  • What are the various initiatives undertaken by big pharma players engaged in the oral solid dosage contract manufacturing market?
  • What are the key factors driving the oral solid dosage manufacturing market?
  • What is the likely growth rate of the oral solid dosage manufacturing market?
  • Which region has the highest market share in the oral solid dosage manufacturing market?
  • What are the leading market segments in the oral solid dosage manufacturing market?
  • What are the upcoming trends in the oral solid dosage manufacturing market?

The financial opportunity within the oral solid dosage manufacturing market has been analyzed across the following segments:

  • Type of Finished Dosage Form
    • Tablets
    • Capsules
    • Granules
    • Powders
    • Others
  • Type of Packaging
    • Bottles
    • Blisters
    • Sachets
    • Strips
    • Stick Packs
  • Scale of Operation
    • Pre-commercial
    • Commercial
  • Company Size
    • Small
    • Mid-sized
    • Large
    • Very Large
  • Therapeutic Areas
    • Oncological Disorders
    • Cardiovascular Disorders
    • Metabolic Disorders
    • Neurological Disorders
    • Genetic Disorders
    • Respiratory Disorders
    • Immunological Disorders
    • Other Disorders
  • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and North Africa

The report includes profiles of key players (listed below) offering oral solid dosage manufacturing; each profile includes a brief overview of the company, along with information on its financial information (if available), service portfolio, recent developments and an informed future outlook.

  • Aenova
  • Alcami
  • Almac
  • Cambrex
  • Catalent
  • Hetero Drugs
  • Ind-Swift
  • Lonza
  • Rubicon Research

For additional details, please visit 

https://www.rootsanalysis.com/reports/oral-solid-dosage-manufacturing-market.html

You may also be interested in the following titles:

1.  Taste Masking and Taste Assessment Services and Technologies Market: Industry Trends and Global Forecasts, 2022-2035

2.  Bioavailability Enhancement Technologies and Services Market: Industry Trends and Global Forecasts, 2022-2035

3.  Pharmaceutical Contract Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2035

4.  Cytotoxic Drugs and HPAPI Manufacturing Market (4th Edition): Industry Trends and Global Forecasts, 2022-2035

Contact:

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com 

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.